.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Markets
News
Corporate
- Corporate Strategist
- Down the Ages
AI
Magazine
OB DataLens
In Depth
Economy & Policy
- Nash Equilibria
Videos
Start-Up
Planet

News
Magazine
Markets
In Depth
Economy & Policy
- Nash Equilibria
Videos
Start-Up
Planet
Corporate
- Corporate Strategist
- Down the Ages
Tech
AI
Budget 2025
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Markets
News
Corporate
AI
Magazine
OB DataLens
In Depth
Economy & Policy
Videos
Start-Up
Planet

home
Topic
Eli lilly

ElI Lilly

Shutterstock : Mounjaro Weight Loss Medicine

US Pharma Firm Eli Lilly Partners with Cipla to Sell Weight-loss Drug in India under Brand Name ‘Yurpeak’

BY Outlook Business Desk

Novo Nordisk Rolls-out Weight-Loss Jab Wegovy In India, Prices Higher Than Lillys Mounjaro

Novo Nordisk Rolls-out Weight-Loss Jab Wegovy In India, Prices Higher Than Lilly's Mounjaro

BY Outlook Business Desk

Eli Lilly Says Its Anti-Obesity Pill Orforglipron Shows Promising Results

Eli Lilly Says Its Anti-Obesity Pill Orforglipron Shows Promising Results

BY Outlook Business Desk

Novo Nordisk and Eli Lilly Bring Weight Loss Contest to India

Novo Nordisk and Eli Lilly Bring Weight Loss Contest to India

BY Vikash Tripathi

Eli Lilly Launches Drug for Obesity, Type 2 Diabetes Treatment

Eli Lilly Launches Drug for Obesity, Type 2 Diabetes Treatment

BY PTI

Cipla Inks Pact with Eli Lilly to Produce, Sell Covid-19 Drug

Cipla Inks Pact with Eli Lilly to Produce, Sell Covid-19 Drug

BY PTI

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2025 Outlook Publishing India Pvt Ltd.

Copyright © 2025 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.